Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $90.9700 (-5.24%) ($88.1100 - $90.9700) on Thu. May. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 29 | Latest Price | $90.9700(-5.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.73% in a week (0% probabilities). VIXM(-23%) UUP(-19%) VXX(-16%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.96(-7.71%) | Resistance Level | $99.43 | 5 Day Moving Average | $93.79(-3.01%) | 10 Day Moving Average | $94.46(-3.69%) | 20 Day Moving Average | $99.43(-8.51%) | To recent high | -27.3% | To recent low | 0% | Market Cap | $1.462b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |